Relay Therapeutics, Inc. RLAY Accrued Liabilities, Current
Accrued Liabilities, Current at other companies
Other financials
Where this comes from
Reported directly by Relay Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AccruedLiabilitiesCurrent.
The official record: Relay Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Relay Therapeutics, Inc.'s accrued liabilities, current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Relay Therapeutics, Inc.'s accrued liabilities, current?
- Relay Therapeutics, Inc. (RLAY) reported accrued liabilities, current of $20.91M in Q1 2026.
- How has Relay Therapeutics, Inc.'s accrued liabilities, current changed year-over-year?
- Relay Therapeutics, Inc.'s accrued liabilities, current decreased by 0.4% year-over-year, from $20.99M to $20.91M.
- What is the long-term trend for Relay Therapeutics, Inc.'s accrued liabilities, current?
- Over 5 years (2020 to 2025), Relay Therapeutics, Inc.'s accrued liabilities, current has grown at a 18.8% compound annual growth rate (CAGR), from $5.76M to $13.65M.